As of Jul 20
| -0.0245 / -2.51%|
The 5 analysts offering 12-month price forecasts for Cytori Therapeutics Inc have a median target of 7.00, with a high estimate of 20.00 and a low estimate of 5.50. The median estimate represents a +636.45% increase from the last price of 0.95.
The current consensus among 5 polled investment analysts is to Buy stock in Cytori Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.